HilleVax Revenue and Competitors
Estimated Revenue & Valuation
- HilleVax's estimated annual revenue is currently $17.2M per year.
- HilleVax's estimated revenue per employee is $366,064
Employee Data
- HilleVax has 47 Employees.
- HilleVax grew their employee count by -54% last year.
HilleVax's People
| Name | Title | Email/Phone |
|---|---|---|
1 | COO & Co-Founder | Reveal Email/Phone |
2 | CEO, President and Chair | Reveal Email/Phone |
3 | General Counsel and Chief Administrative Officer | Reveal Email/Phone |
4 | Chief Technology Officer | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Chief Operating Officer | Reveal Email/Phone |
7 | VP Quality | Reveal Email/Phone |
8 | VP Clinical Development | Reveal Email/Phone |
9 | SVP | Reveal Email/Phone |
10 | VP, Program Management | Reveal Email/Phone |
HilleVax Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is HilleVax?
N/A
Total Funding
47
Number of Employees
$17.2M
Revenue (est)
-54%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HilleVax News
2022-04-17 - Norovirus vaccine developer HilleVax files for $100M IPO
HilleVax has been developing vaccine called HIL-214 for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection...
2022-04-13 - HilleVax Targets $100 Million IPO For Acute Gastroenteritis Vaccine
HilleVax has booked fair market value investment of $158 million in convertible promissory notes from investors including Frazier Life Sciences...
2022-04-06 - HilleVax, a Biopharma Developing Vaccines, Is Going Public
HilleVax, which was formed by Takeda Pharmaceutical and private-equity firm Frazier Healthcare Partners, is going public.
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 47 | -6% | N/A |
#2 | $5.6M | 47 | 21% | N/A |
#3 | $6.5M | 47 | 18% | N/A |
#4 | $12.3M | 47 | 24% | N/A |
#5 | $9.4M | 47 | 0% | N/A |